Aim: Our aim is to evaluate patients whom operated for spinal tumor according to symptoms, pathology, level of tumor, grade of tumor and demographic data’s.Material and Method: We inspected patients whom operated for spinal tumor for the last five years retrospectively. Data collected from the patient files and radiology PACS system. Spinal tumors inspected according to symptoms, pathology, level of tumor, grade of tumor and demographic data of patients.Results: A total of 37 patients were included in this study. The mean age of the participants was 50.8 ± 15.7 years, and 54.1 % of the population were males. Most frequent complaints were weakness in legs (24.3 %), low back pain (35.1 %), arm/leg pain (35.1 %), and gait disturbance (16.2 %). Accordingly, most frequent pathological diagnoses were meningioma (29.7 %), schwannoma (27 %), and ependymomas (10.8 %); most frequent disease grade was 1 (76.7 %), and most frequent sites of localization were L2 and L3 (21.6 % each). Accordingly, only age was significantly higher in men than women (p=0,029), and remaining characteristics of patients were similar between genders (p>0.05 for all).Conclusion: Total resection of spinal tumors improve recovery of neurological deficits, reduce symptoms and give a chance for oncological treatment modalities


1. Arrigo RT, Kalanithi P, Cheng I, Alamin T, Carragee EJ, Mindea SA, Boakye M, Park J. Predictors of survival after surgical treatment of spinal metastasis. Neurosurgery 2011; 68(3): 674-681.

2. Clarke MJ, MD, Vrionis FD. Spinal tumor surgery: management and the avoidance of complications. Cancer Control 2014; 21(2): 125-132.

3. Fisher CG, Goldschlager T, Boriani S, Varga PP, Rhines LD, Fehlings MG, Luzzati A, Dekutoski MB, Reynolds JJ, Chou D, Berven SH, Williams RP, Quraishi NA, Bettegowda C, Gokaslan ZL. A novel scientific model for rare and often neglected neoplastic conditions. Evid Based Spine Care J 2013; 4(2): 160–162.

4. Gokaslan ZL, York JE, Walsh GL.. Transthoracic vertebrectomy for metastatic spinal tumors. J Neurosurg 1998; 89(4): 599-609.

5. Harel R, Angelov L. Spine metastases: current treatments and future directions. Eur J Cancer 2010; 46(15): 2696- 2707.

6. Laufer I, Sciubba DM, Madera M, Bydon A, Witham TJ, Gokaslan ZL, Wolinsky JP. Surgical management of metastatic spinal tumors. Cancer Control 2012; 19(2): 122- 128.

7. Mechtler LL, Nandigam K. Spinal cord tumors: new views and future directions. Neurol Clin 2013; 31(1): 241–268.

8. Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, Mohiuddin M, Young B. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet 2005; 366(9486): 643-648.

9. Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL, Rhines LD, Gokaslan ZL. Diagnosis and management of metastatic spine disease. A review. J Neurosurg Spine 2010; 13(1): 94-108.

10. Wang JC, Boland P, Mitra N, Yamada Y, Lis E, Stubblefield M, Bilsky MH. Single-stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Invited submission from the Joint Section Meeting on Disorders of the Spine and Peripheral Nerves, March 2004. J Neurosurg Spine 2004; 1(3): 287-298.

11. Wilson DA, Fusco DJ, Uschold TD, Spetzler RF, Chang SW. Survival and functional outcome after surgical resection of intramedullary spinal cord metastases. World Neurosurg 2012; 77(2):3 70–374.

Kaynak Göster